442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Effective March 1, 2025, LXP Industrial Trust appointed Nathan Brunner as Executive Vice President, Chief Financial Officer and Treasurer, replacing Beth Boulerice, who remains with the Trust in an advisory role. Brunner joined the Trust in September 2024 as Executive Vice President of Capital Markets and previously spent about 14 years as an investment banker at J.P. Morgan.
Brunner's current annual base salary is $500,000, under a letter agreement dated May 24, 2024.
He received a $250,000 cash bonus and a 150,000 nonvested common share award when he joined in September 2024.
His 2025 annual cash incentive is $504,804, of which $402,954 was paid in January 2025 and $101,850 is expected in March 2025.
Xcel Energy said Chief Operations Officer Timothy O'Connor will retire this summer, after notice given February 25, 2025. Internal executives Michael Lamb and Scott Sharp will take on new executive vice president roles effective May 1, 2025, under the company's succession planning process. O'Connor will provide transition services through August 21, 2025.
Timothy O'Connor, EVP and Chief Operations Officer, will retire May 1, 2025 and provide transition services through August 21, 2025.
Michael Lamb becomes EVP, Chief Delivery Officer effective May 1, 2025; he joined Xcel Energy in 1985.
Scott Sharp becomes EVP, Chief Generation Officer effective May 1, 2025, adding oversight of Nuclear; he joined in 2000.
Lamb and Sharp will report to Chairman, President and CEO Bob Frenzel and serve on the Executive Committee.
Haemonetics appointed Frank W. Chan, Ph.D., former President of Medtronic's Acute Care & Monitoring business, as Executive Vice President and Chief Operating Officer, effective April 7, 2025, and promoted Roy Galvin to Executive Vice President and Chief Commercial Officer effective immediately. The filing describes these as leadership changes in the executive team; it reports no financial results or guidance, so it does not change reported figures.
Frank W. Chan, Ph.D., 55, starts as COO on April 7, 2025, overseeing R&D, regulatory, global manufacturing and supply chain, and reporting to CEO Christopher A. Simon
Chan's pay includes a $550,000 base salary, a target bonus of 80% of base salary, and a long-term equity award target value of $1,600,000, subject to Compensation Committee approval
Chan receives a $350,000 sign-on bonus, with $300,000 repayable in the first 12 months and $150,000 repayable between months 12 and 24 if he leaves voluntarily or is terminated for cause
Roy Galvin's expanded CCO role covers Global Hospital, Global Plasma and Blood Center; Stewart Strong, President, Global Hospital, stays in his role through April 1, 2025, then advises the CEO temporarily
ADMA Biologics reported full-year 2024 total revenue of $426.5 million, up 65% from 2023, and GAAP net income of $197.7 million, which includes an $84.3 million valuation allowance tax benefit. It raised its FY 2025 and 2026 revenue, Adjusted Net Income and Adjusted EBITDA guidance, but said it expects to file its Form 10-K late, on or before March 18, 2025, because KPMG has not yet completed its audit procedures.
FY 2024 revenue $426.5 million vs. $258.2 million in FY 2023; GAAP net income $197.7 million vs. a net loss of $28.2 million
FY 2024 Adjusted EBITDA $164.6 million and Adjusted Net Income $119.2 million, vs. $40.2 million and $0.7 million in FY 2023
FY 2025 total revenue guidance raised to more than $490 million; FY 2026 to more than $605 million
Company intends to file a Form 12b-25 and expects to file the Form 10-K on or before March 18, 2025; KPMG has not completed its audit procedures
PriceSmart said Robert Price will step down as interim CEO effective August 31, 2025, and his son David Price will become CEO effective September 1, 2025. Robert Price will become Executive Chairman of the Board. The filing does not disclose any change to David Price's compensation, which the company says will be set later.
Robert Price, interim CEO since February 2023, steps down August 31, 2025 and becomes Executive Chairman
David Price, EVP and Chief Transformation Officer and a board member since February 2022, becomes CEO September 1, 2025
Compensation for David Price will be adjusted; the company will file an 8-K amendment once it is determined and approved
The filing discloses about $336,000 of supply sales to Price Philanthropies Foundation and a $150,000 contribution to PriceSmart Foundation, both tied to David Price's roles
Match Group appointed Hesam Hosseini, currently CEO of Evergreen & Emerging Brands, as Chief Operating Officer effective April 1, 2025, and entered into an employment agreement with him with a $635,000 base salary. President Gary Swidler will step down from that role on April 1, 2025, and remain an employee advisor until July 4, 2025.
Hesam Hosseini appointed Chief Operating Officer effective April 1, 2025, in addition to his current CEO role for Evergreen & Emerging Brands
Hosseini's employment agreement sets a $635,000 annual base salary and a discretionary bonus target of 150% of base salary
Gary Swidler, President, steps down April 1, 2025, and serves as an employee advisor until July 4, 2025
On March 3, 2025, Valley National Bancorp announced several senior executive changes. Gino Martocci, formerly Head of Commercial and Commercial Real Estate Banking at M&T Bank, will become Senior Executive Vice President and President of Commercial Banking effective March 31, 2025, succeeding Joseph Chillura, who will separate from the company June 30, 2025. Travis Lan was promoted to Senior Executive Vice President and Chief Financial Officer effective immediately, with his base salary raised 25%, target bonus raised 50% and target long-term incentive award raised 76%, and Russell Barrett was named Chief Operating Officer effective immediately.
Gino Martocci joins as President of Commercial Banking effective March 31, 2025, with over 30 years of banking experience
Joseph Chillura leaves the commercial banking president role March 31, 2025 and separates from the company June 30, 2025; the filing says his departure is not due to any disagreement
Travis Lan named Senior Executive Vice President, CFO effective immediately; base salary up 25%, target bonus up 50%, target long-term incentive up 76%
Russell Barrett named Senior Executive Vice President, Chief Operating Officer effective immediately; he joined in 2021
Dave Operating LLC, a subsidiary of Dave Inc., entered a Program Agreement dated February 27, 2025 with Coastal Community Bank, under which Coastal will be the sole provider of Program features for new Dave customers and Dave-branded deposit accounts and cards. Dave will market and service the Program, pay Coastal tiered and minimum monthly fees, and receive interchange revenue and customer fees, while Dave Inc. guarantees Dave Operating's obligations under a separate Assurance Agreement. The filing says the arrangement matters because it changes Dave's bank partner structure and carries ongoing fee and guarantee commitments for shareholders.
Program Agreement effective February 27, 2025, with an initial term of about five years
Coastal shares all interchange revenue from Card transactions; Dave pays a tiered fee based on Card transaction volume and a minimum monthly fee absent certain conditions
Coastal may keep up to $100 million of each of certain receivable types on its balance sheet; Dave is responsible for certain charge-offs, third-party fraud losses and first-payment defaults
Existing customers are to transition to Coastal within 24 months after Dave completes beta testing; the press release says customer onboarding could begin as soon as Q2 2025
TG Therapeutics reported fourth-quarter and full-year 2024 results, with full-year total revenue of $329.0 million and net income of $23.4 million, compared with $233.7 million and $12.7 million in 2023. The company set a 2025 target of approximately $540 million in total global revenue and said its $311.0 million in cash, cash equivalents and investment securities, combined with projected BRIUMVI revenue, should fund the business under its current operating plan.
Q4 2024 total revenue was $108.2 million, compared with $44.0 million in Q4 2023; Q4 2024 net income was $23.3 million, compared with a net loss of $14.4 million.
Full-year 2024 total revenue was $329.0 million, compared with $233.7 million in 2023; 2023 included recognition of a one-time $140.0 million Neuraxpharm upfront payment.
2025 target total global revenue is approximately $540 million, including BRIUMVI U.S. net product revenue of approximately $525 million.
Cash, cash equivalents and investment securities were $311.0 million as of December 31, 2024.
Kroger said Chairman and CEO Rodney McMullen resigned effective immediately after a Board investigation into his personal conduct, which the company says is unrelated to its financial performance, operations or reporting. Lead Director Ronald Sargent became interim CEO and Chairman, and the company said full-year Identical Sales without fuel are expected at the high end of guidance and Adjusted EPS slightly above the high end of guidance. Shareholders will get full 2024 results and 2025 guidance on March 6, 2025.
Rodney McMullen resigned as Chairman and CEO effective immediately; he forfeits unvested equity awards and will not receive a 2024 bonus.
Ronald Sargent, a director since 2006 and Lead Director since 2017, is interim CEO and Chairman; a Search Committee is seeking a permanent CEO.
Mark Sutton was appointed Lead Director.
Full-year Identical Sales without fuel expected at the high end of guidance; Adjusted EPS expected slightly above the high end of guidance.
SolarEdge appointed Asaf Alperovitz as Chief Financial Officer, effective immediately, after CFO Ariel Porat notified the board on March 2, 2025 that he was stepping down for personal reasons. Alperovitz will also serve as principal accounting officer, and Porat will stay on as a non-officer employee for a six-month transition period.
Asaf Alperovitz appointed CFO and principal accounting officer effective March 2, 2025
Ariel Porat stepped down as CFO on a personal decision and will remain as a non-officer employee for six months
Alperovitz's pay includes a 75% target annual bonus, RSUs valued at about $600,000 and PSUs valued at about $900,000
Alperovitz previously served as CFO of Delta Galil Industries from 2019 to 2024
N-able reported fourth-quarter 2024 total revenue of $116.5 million, up 7.5% year over year, and said this exceeded its fourth-quarter revenue guidance. GAAP net income for the quarter was $3.3 million, or $0.02 per diluted share, compared with $9.35 million a year earlier. For 2025, the company expects total revenue of $486.5 million to $492.5 million, growth of about 4% to 6% after 10.5% growth in 2024, which signals a slowdown for shareholders.
Q4 2024 revenue $116.5 million, up 7.5%; GAAP net income $3.3 million ($0.02 per diluted share) versus $9.35 million in Q4 2023
Full-year 2024 revenue $466.1 million, up 10.5%; GAAP net income $31.0 million ($0.16 per diluted share)
2025 outlook: total revenue $486.5 million to $492.5 million; adjusted EBITDA $132.0 million to $138.0 million; total ARR $514.0 million to $522.0 million
Q1 2025 outlook: revenue $115.0 million to $116.0 million, about 1% to 2% year-over-year growth
Microchip Technology announced additional restructuring, including about 2,000 headcount reductions across its fabs, Philippines backend facility and business units, and a closure of its Tempe, Arizona Fab 2 that is now expected to finish in May 2025, several months earlier than planned. The company estimates $30 million to $40 million in related costs and about $45 million in charges tied to canceling or modifying long-term wafer supply agreements, against expected annualized operating expense savings of $90 million to $100 million.
About 2,000 headcount reductions, starting March 3, 2025, with full implementation expected by the end of the June 2025 quarter
Estimated restructuring costs of $30 million to $40 million, including cash severance and other related charges
Expected charges of about $45 million tied to canceling or modifying long-term wafer foundry supply agreements
Expected annualized operating expense reductions of $90 million to $100 million, plus about $25 million in additional factory employment cost savings
Celsius Holdings named Eric Hanson, a 30-year food and beverage veteran who most recently led PepsiCo's strategic partnerships unit, as President and Chief Operating Officer, effective March 24, 2025. CEO John Fieldly stays on as CEO and Chairman, and Hanson takes over Fieldly's current title of President.
Eric Hanson, 53, appointed President and Chief Operating Officer; effective March 24, 2025
Hanson's base salary is $700,000 per year, plus a $1,150,000 annual equity award and a one-time $1,200,000 restricted stock unit award
Hanson has been with PepsiCo since 1997, most recently as Senior Vice President, Strategic Partnerships
VIAVI signed an asset purchase agreement with Keysight Technologies to buy the high-speed ethernet and network security business lines of Spirent Communications for a $410 million base price paid at closing, plus $15 million of contingent cash consideration. The deal depends on Keysight's pending acquisition of Spirent and on regulatory approvals, and is expected to close in the second quarter of calendar 2025. VIAVI has also secured commitments for a $425 million senior secured term loan to fund the purchase, and the company expects the business to add about $180 million to its NSE revenue in the first 12 months after closing.
Base purchase price of $410 million paid at closing, plus $15 million contingent on certain metrics before closing
Expected close in the second quarter of calendar 2025, subject to regulatory approvals and closing of Keysight's Spirent acquisition
Committed $425 million senior secured term loan facility to fund the acquisition
Company expects about $180 million of added NSE revenue in the first 12 months after closing and EPS accretion 12 months after closing
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.